highly significantP < 0.01
Frequency and onset of neurological adverse effects like paresthesia, dizziness, and hypoesthesia were significantly different ( P < 0.05), whereas frequency and onset of peripheral neuropathy were highly significant ( P < 0.01) in each treatment arm of FOLFOX.